May 2024
Husch Blackwell: DEA Will Reschedule Cannabis to a Schedule III Drug
The biggest legal shift in the cannabis industry in decades just occurred on the heels of the Drug Enforcement Administration’s ...
Dorsey Whitney: It is a momentous day but lots more to come
“Cannabis is currently a Schedule 1 drug which includes drugs like heroin and LSD. The Biden administration is moving it ...
Prince Lobel: Client Alert: DEA to Reclassify Cannabis
Today the Associated Press broke the news of the DEA’s long-awaited decision to move forward with the plan to reclassify cannabis from Schedule ...
mcglinchey: Marijuana Rescheduling is Here: How DEA’s Decision Will Impact Cannabis Businesses
After fifty years, the federal government finally acknowledged that marijuana has medical value and is not as dangerous as heroin ...
mcglinchey: “Hemp-Derived” THC in Massachusetts: Navigating the Regulatory Maze
The recent proliferation of intoxicating hemp products containing “hemp-derived” THCs in Massachusetts restaurants, liquor stores, and convenience shops has sparked ...
Harambe: Submissions in Re: Cannabis For Private Purposes Bill (B19-2020)
The cornerstone of these submissions is that the constitutional rights to privacy and the right to freedom of association respectively ...
Fox Rothschild: Employees Self-Medicating with Adult Use Marijuana Creates Pitfalls for Employers and Employees
Currently, 38 states have permitted use of medical marijuana in their states and many of those states provide some level ...
Dentons: Peter Homberg Makes His ICBC Address Publicly Avaialble For All To Read
Following my presentation at the ICBC on April 16 I would like to make my slides available to everyone who ...
Jacoby Law: Batch Tagging Tracker: OLCC Files Permanent Administrative Order Delaying Batch Tagging Implementation to June 2024
Last week on April 18th, OLCC filed a permanent administrative order that finalizes the rule delaying a batch tagging system until June ...
Rod Kight: A New Vision for Cannabis Reform (VIDEO) – The Three Pillar Approach
I gave a keynote speech at the 10th annual NoCo Hemp Expo in Estes Park, CO, put on by my friend and ...
SA: Testing positive for cannabis at work in South Africa – what you need to know
A zero-tolerance policy against the use of cannabis may infringe on an employee’s right to privacy and dignity, as a ...
Jenner & Block: Cannabis in Court – When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business
The unique status of the cannabis business — legal in a majority of states, but still illegal under federal law ...
Licks Attorneys: Automatic cancellation of Cannabis Products’ authorizations by Anvisa: incentive or setback?
Anvisa’s (the Brazilian FDA) regulation for Cannabis Products, Rule #327/2019, provides that, until the end of the 5-year period of ...
CMS Expert Guide To Cannabis Law And Legislation
In recent years cannabis trade and related activity has developed into a growth business area. In the life sciences and ...
ABA Jnl – Extract: Pulling the Weed: Bankruptcy opinion shows debt restructure path for cannabis workers
Bankruptcy courts generally have been a rather hostile forum for debtors employed in the marijuana industry. While 24 states have legalized recreational ...
Arent Fox Schiff: District of Columbia Medical Cannabis Amendment Act Makes Sweeping Changes to Local Cannabis Laws
Medical marijuana has been legal in DC since 2011. In recent years, the District has adopted piecemeal amendments to its ...
Cole Schotz: Third Party Advertising Gets the Green Light in NY’s Adult-Use Market
On April 4, 2024, New York Supreme Court Justice Kevin Bryant struck down the state’s ban on third-party cannabis marketing ...
Harris Beach: Judge Strikes Down New York’s Cannabis Marketing Rules
In a sharp rebuke to New York’s Cannabis Control Board, state Supreme Court judge Kevin R. Bryant dealt a blow ...
Fox Rothschild: IRS Issues New Guidance for Cannabis Companies That Receive Over $10K in Cash
The IRS’s Office of Chief Counsel recently published a memorandum providing information for cannabis companies struggling to comply with the ...
Gardner FDA Law Firm: FDA’s View on Cannabis
The U.S. Food and Drug Administration (FDA) is continuing to support clinical research for cannabis and psychedelic drug development. On ...
Bradley: The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program
Well, it’s here. Late yesterday afternoon Sens. Tim Melson and David Sessions introduced the long-awaited “legislative fix” to help get ...